PL
TEVA icon

Perpetual Ltd’s Teva Pharmaceuticals TEVA Stock Holding History

Perpetual Ltd’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-86,252
Closed -$2.87M – 237
2017
Q2 		$2.87M Buy
+86,252
New +$2.67M 0.22% 120
2016
Q4 		– Sell
-51,852
Closed -$2.39M – 222
2016
Q3 		$2.39M Buy
+51,852
New +$2.71M 0.2% 123
2013
Q4 		– Sell
-234,300
Closed -$8.85M – 241
2013
Q3 		$8.85M Sell
234,300
-9,900
-4% -$386K 1.24% 23
2013
Q2 		$9.57M Buy
+244,200
New +$9.51M 1.44% 21

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Perpetual Ltd's TEVA Position: Q3 2017 in Review

Perpetual Ltd sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 86,252 shares — an estimated $2.87M sold.

Perpetual Ltd first reported a position in TEVA in Q2 2013 and held it in 4 quarters. The position peaked at $9.57M in Q2 2013. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Perpetual Ltd reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Perpetual Ltd sold 86,252 Teva Pharmaceuticals shares in Q3 2017, an estimated $2.87M.
  • Perpetual Ltd first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Perpetual Ltd's Teva Pharmaceuticals position peaked at $9.57M in Q2 2013.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Perpetual Ltd's 13F filing for Q3 2017, filed 1 Nov 2017.